Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

NUWE vs YBGJ: stock comparison and AI forecast

Nuwellis, Inc. (NUWE) and Yubo International Biotech Ltd (YBGJ) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Electromedical & Electrotherapeutic Apparatus

NUWE Nuwellis, Inc.

Market Cap
$2M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
OTC · Electromedical & Electrotherapeutic Apparatus

YBGJ Yubo International Biotech Ltd

Price
$0.01 -35.7% · 6M
Market Cap
n/a
P/E Ratio
–
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

NUWE · YBGJ

Key facts

  • Both companies share the SEC industry classification Electromedical & Electrotherapeutic Apparatus.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricNUWEYBGJ
Market Cap$2M–
EPS–$-0.01

Profitability & Margins

MetricNUWEYBGJ
Gross Margin69.7%–
Operating Margin-142.9%–
EBT Margin-125.6%–
Tax Rate0.0%0.0%

Financial Health

MetricNUWEYBGJ
Current Ratio1.97x0.18x
Quick Ratio1.54x0.17x
Interest Coverage-59.7x7298.4x
Working Capital–-$3M

Cash Flow

MetricNUWEYBGJ
Operating Cash Flow–-$780K
FCF/Sales-139.7%–
CapEx/Sales1.4%–

Operational Efficiency

MetricNUWEYBGJ
Asset Turnover0.99x–
Receivables Turnover5.8x0.1x
Inventory Turnover1.6x0.2x
Fixed Assets Turnover26.0x0.7x
Days Sales Outstanding63 days4079 days
Days Inventory233 days2162 days
Payables Period387 days113947 days
Cash Conversion Cycle-92 days-107706 days

Income Statement

MetricNUWEYBGJ
Total Revenue–$10K
Operating Income–-$1M
Net Income–-$920K
Cost of Goods Sold–$0.00M

Dividend & Shareholder Information

MetricNUWEYBGJ
Shares Outstanding0M–
FAQ

NUWE vs YBGJ: stock comparison and AI forecast

Which one does Intratio's AI model rank higher, NUWE or YBGJ?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.